Provided by Tiger Trade Technology Pte. Ltd.

Beam Therapeutics, Inc.

25.17
+0.54002.19%
Post-market: 25.170.00000.00%16:49 EDT
Volume:1.29M
Turnover:32.73M
Market Cap:2.55B
PE:-31.07
High:25.76
Open:25.34
Low:24.97
Close:24.63
52wk High:36.44
52wk Low:13.53
Shares:101.47M
Float Shares:89.94M
Volume Ratio:0.72
T/O Rate:1.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8100
EPS(LYR):-0.8100
ROE:-8.11%
ROA:-18.55%
PB:2.06
PE(LYR):-31.07

Loading ...

Hitachi Cooling & Heating Supports Hong Kong's Net-Zero Transition with BEAM Plus-Aligned VRF Solutions

prnewswire
·
Yesterday

Analysts Are Bullish on These Healthcare Stocks: Beam Therapeutics (BEAM), Pelthos Therapeutics (PTHS)

TIPRANKS
·
Mar 16

H.C. Wainwright Keeps Their Buy Rating on Beam Therapeutics (BEAM)

TIPRANKS
·
Mar 10

Beam Therapeutics Inc - on March 2, Co and Bio Palette Mutually Terminate License Agreement Dated March 27, 2019 - SEC Filing

THOMSON REUTERS
·
Mar 06

Assessing Beam Therapeutics (BEAM) Valuation After Q4 Earnings Surprise Credit Facility And PKU Program Launch

Simply Wall St.
·
Feb 28

Beam Therapeutics President Giuseppe Ciaramella Disposes of Common Shares

Reuters
·
Feb 27

Stock Track | Beam Therapeutics Soars 5.23% Intraday on Analyst Upgrades

Stock Track
·
Feb 25

Clear Street Reaffirms Their Buy Rating on Beam Therapeutics (BEAM)

TIPRANKS
·
Feb 25

U.S. RESEARCH ROUNDUP-Chevron, GoDaddy, HP

Reuters
·
Feb 25

What's Going On With Beam Therapeutics Stock?

Benzinga_recent_news
·
Feb 25

Beam Therapeutics announces $500M financing facility

TIPRANKS
·
Feb 24

Beam Therapeutics Secures $500 Million Credit Facility

TIPRANKS
·
Feb 24

Earnings Flash (BEAM) Beam Therapeutics Posts Q4 EPS $2.33, vs. FactSet Est of $1.01 Loss

MT Newswires Live
·
Feb 24

Beam Therapeutics tops Q4 profit estimates, signs financing deal

Reuters
·
Feb 24

Beam Q4 net income attributable to common stockholders hits USD 244.3 million

Reuters
·
Feb 24

Beam Therapeutics Secures $500 Million Financing Facility With Sixth Street

Reuters
·
Feb 24

Beam Therapeutics Inc - Secures up to $500 Mln Non-Dilutive Capital From Sixth Street

THOMSON REUTERS
·
Feb 24

Beam Therapeutics Inc - Plans Ind Filing for Beam-304 With FDA in 2026

THOMSON REUTERS
·
Feb 24

Beam Therapeutics Q4 License and Collaboration Revenue USD 114.109 Million

THOMSON REUTERS
·
Feb 24

Beam Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Announces New Liver-Targeted Genetic Disease Program in Phenylketonuria (PKU)

GlobeNewswire
·
Feb 24